Form 4: BullFrog AI Director Enright Receives Stock Options

BullFrog AI Holdings, Inc. director William Enright was granted 15,000 stock options with an exercise price of $1.43 under the company's 2022 Equity Compensation Plan.

Summary

• William Enright, a director of BullFrog AI Holdings, Inc. (BFRG), was granted 15,000 stock options.
• The options have an exercise price of $1.43 per share.
• These options were issued under the Company's 2022 Equity Compensation Plan.
• The options vest on the earlier of September 25, 2026, or the date of the Company's annual meeting for fiscal year 2026.
• Forfeiture restrictions will accelerate upon a change in control of the Company or a significant financing event.
• The stock options expire on September 25, 2035.
• The options were granted at a price of $0.00, based on the market price on the grant date.

Sentiment

Score: 6

Explanation: The filing reports a routine equity grant to a director, which is generally a neutral to slightly positive event as it aligns management interests with shareholders. It does not contain any unexpected positive or negative financial news.

Positives

• The grant of stock options to Director William Enright aligns his interests with those of shareholders, incentivizing long-term company performance.
• The options were issued under an established 2022 Equity Compensation Plan, indicating a structured approach to executive incentives.

Risks

• The value of the stock options is dependent on the future market price of BullFrog AI Holdings, Inc. common stock exceeding the $1.43 exercise price.
• Options are subject to forfeiture restrictions if vesting conditions are not met, though acceleration conditions exist for change in control or significant financing.

Future Outlook

The stock options granted to Director William Enright are set to vest on the earlier of September 25, 2026, or the date of the Company's annual meeting for fiscal year 2026. The options will expire on September 25, 2035, and forfeiture restrictions may accelerate upon a change in control or significant financing.

Management Comments

• The options were issued as a grant under the Plan, based on the market price on the date of the grant.

Industry Context

The grant of stock options to directors is a common practice in the biotechnology and technology sectors, aiming to align the interests of management and board members with those of shareholders by providing long-term equity incentives. This practice is standard across publicly traded companies, particularly those in growth-oriented industries like AI and biotech, where long-term value creation is paramount.

Comparison to Industry Standards

• The grant of 15,000 stock options to a director is a typical size for a company of BullFrog AI's profile, comparable to grants seen at similar-stage biotech or AI firms.
• An exercise price of $1.43, based on the market price at the grant date, is standard practice for incentive stock options, ensuring that the options only gain value if the company's stock price appreciates.
• The vesting schedule, tied to a future date or annual meeting, is a common mechanism to retain directors and incentivize sustained performance, similar to practices at companies like Recursion Pharmaceuticals or C3.ai for their board members.

Corporate Governance

Related Party Transactions

• Grant of 15,000 stock options to William Enright, a director of BullFrog AI Holdings, Inc., under the company's 2022 Equity Compensation Plan.

Stakeholder Impact

• Shareholders: The grant aligns the director's financial interests with shareholder value creation, as the options gain value only if the stock price increases.
• Employees: The existence of an equity compensation plan suggests a broader framework for incentivizing key personnel, potentially boosting morale and retention.

Next Steps

• The stock options will vest on the earlier of September 25, 2026, or the date of the Company's annual meeting for fiscal year 2026.
• The options will become exercisable upon vesting and expire on September 25, 2035.

Key Dates

Recommendation

This Form 4 filing details a routine grant of stock options to a director, which is a standard practice for executive compensation and aligns the director's interests with the company's long-term performance. It does not provide new material financial or operational information that would warrant a change in investment recommendation. Investors should 'hold' and consider this a neutral event in the context of their broader investment thesis for BullFrog AI Holdings, Inc.

Keywords

BullFrog AI, BFRG, William Enright, stock options, equity compensation, Form 4, insider transaction, director compensation, vesting, equity plan